The impact of systemic precision medicine and immunotherapy treatments on brain metastases

Authors

Rowland H. Han, Washington University School of Medicine in St. Louis
Gavin P. Dunn, Washington University School of Medicine in St. Louis
Milan G. Chheda, Washington University School of Medicine in St. Louis
Albert H. Kim, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

11-19-2019

Volume

10

Issue

62

First Page

6739

Last Page

6753

Document Type

Open Access Publication

DOI

10.18632/oncotarget.27328

Rights and Permissions

Han RH, Dunn GP, Chheda MG, Kim AH. The impact of systemic precision medicine and immunotherapy treatments on brain metastases. Oncotarget. 2019 Nov 19;10(62):6739-6753. doi: 10.18632/oncotarget.27328. eCollection 2019 Nov 19. Copyright: Han et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Han, Rowland H.; Dunn, Gavin P.; Chheda, Milan G.; and Kim, Albert H., "The impact of systemic precision medicine and immunotherapy treatments on brain metastases." Oncotarget. 10, 62. 6739 - 6753. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8579